mmm-20221216

0000066740-22-000085.txt : 20221220 0000066740-22-000085.hdr.sgml : 20221220 20221220063350 ACCESSION NUMBER: 0000066740-22-000085 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221216 ITEM INFORMATION: Material Impairments ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221220 DATE AS OF CHANGE: 20221220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 3M CO CENTRAL INDEX KEY: 0000066740 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 410417775 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03285 FILM NUMBER: 221472804 BUSINESS ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-13E-26A CITY: ST PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 6517331474 MAIL ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-13E-26A CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: MINNESOTA MINING & MANUFACTURING CO DATE OF NAME CHANGE: 19920703 8-K 1 mmm-20221216.htm 8-K mmm-20221216

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 16, 2022

3M COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Delaware

File No. 1-3285

41-0417775

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

3M Center, St. Paul, Minnesota

55144-1000

(Address of Principal Executive Offices)

(Zip Code)

(Registrant’s Telephone Number, Including Area Code) (651) 733-1110

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $.01 Per Share

MMM

New York Stock Exchange

MMM

Chicago Stock Exchange, Inc.

0.950% Notes due 2023

MMM23

New York Stock Exchange

1.500% Notes due 2026

MMM26

New York Stock Exchange

1.750% Notes due 2030

MMM30

New York Stock Exchange

1.500% Notes due 2031

MMM31

New York Stock Exchange

Note: The common stock of the Registrant is also traded on the SWX Swiss Exchange.

Securities registered pursuant to section 12(g) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act. ☐

Item 2.06. Material Impairments

As a result of authorization by 3M Company’s Board of Directors on December 16, 2022 of the plan to exit per- and polyfluoroalkyl substance (PFAS) manufacturing by the end of 2025, 3M expects to incur an estimated pre-tax charge in a range of $0.7 billion to $1.0 billion in the fourth quarter of 2022, primarily non-cash and related to asset impairments. These impairments, in and of themselves, are not expected to result in material future cash expenditures.

Item 7.01. Regulation FD

On December 20, 2022, 3M Company issued a press release announcing its plan to exit all PFAS manufacturing by the end of 2025 and work to discontinue use of PFAS across the Company’s product portfolio by the end of 2025. A copy of the press release is furnished as Exhibit 99.1 hereunder and is incorporated by reference herein.

Forward-Looking Statements

This report contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance, future costs to be incurred or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2021, as updated by the Company's Current Report on Form 8-K dated April 26, 2022, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company's Health Care business, including whether the transaction will be completed, or if completed, will be on the expected terms; the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; the ability to satisfy the various closing conditions; potential business disruption; the diversion of management time; the impact of the transaction (or its pendency) on the Company's ability to retain talent; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment (including whether an Internal Revenue Service private letter ruling will be sought or obtained); the risk that any consents or approvals required will not be obtained; risks associated with financings that may be undertaken and indebtedness that may be incurred in connection with the transaction; (16) matters relating to the voluntary chapter 11 proceedings of the Company's subsidiary Aearo Technologies and certain of its affiliates (the "Aearo Entities"), including legal risks related to the chapter 11 proceedings; potential impacts to the Company's reputation and its relationships with customers, suppliers, employees, regulators and other counterparties and community members; potential impacts to the Company's liquidity or results of operations, including risks related to the amount that will be necessary to fully and finally resolve all of the Company's obligations to make payments to resolve such claims under the terms of its funding and indemnification agreement with the Aearo Entities; and the Aearo Entities' ability to navigate the chapter 11 proceedings to obtain approval and consummation of a plan of reorganization; (17) matters relating to the Company’s plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio (the “exit”), including the actual timing, costs and financial impact of such exit; the Company’s ability to complete such exit, on the anticipated timing or at all; potential governmental or regulatory actions relating to PFAS manufacturing and production, or the Company’s exit plans; the Company’s ability to identify and manufacture acceptable substitutes for the discontinued products, and the possibility that such substitutes will not achieve the anticipated or desired commercial or operational results; potential litigation relating to the Company’s exit plans; and the possibility that the planned exit will involve greater costs than anticipated, or otherwise have negative impacts on the Company’s relationships with its customers and other counterparties. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no

obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits


Exhibit Number						Description
99.1						Press Release, dated as of December 20, 2022, of 3M Company (furnished pursuant to Item 7.01 hereof)
104						Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			3M COMPANY

			By:			/s/ Michael M. Dai

						Michael M. Dai,
						Vice President, Associate General Counsel & Secretary

Dated: December 20, 2022

EX-99.1 2 a1220228kex-991.htm EX-99.1 Document

Exhibit 99.1

3M to Exit PFAS Manufacturing by the End of 2025

ST. PAUL, MN –3M (NYSE: MMM) today announced it will exit per- and polyfluoroalkyl substance (PFAS) manufacturing and work to discontinue the use of PFAS across its product portfolio by the end of 2025. 3M’s decision is based on careful consideration and a thorough evaluation of the evolving external landscape, including multiple factors such as accelerating regulatory trends focused on reducing or eliminating the presence of PFAS in the environment and changing stakeholder expectations.

“This is a moment that demands the kind of innovation 3M is known for,” said 3M chairman and chief executive officer Mike Roman. “While PFAS can be safely made and used, we also see an opportunity to lead in a rapidly evolving external regulatory and business landscape to make the greatest impact for those we serve. This action is another example of how we are positioning 3M for continued sustainable growth by optimizing our portfolio, innovating for our customers, and delivering long-term value for our shareholders.”

3M will:

•Exit all PFAS manufacturing by the end of 2025: 3M will discontinue manufacturing all fluoropolymers, fluorinated fluids, and PFAS-based additive products. We will help facilitate an orderly transition for customers. 3M intends to fulfill current contractual obligations during the transition period.

•Work to discontinue use of PFAS across our product portfolio by the end of 2025: We have already reduced our use of PFAS over the past three years through ongoing research and development, and will continue to innovate new solutions for customers.

With these two actions, 3M is committing to innovate toward a world less dependent upon PFAS. 3M’s products are safe for their intended uses. 3M will continue to remediate PFAS and address litigation by defending ourselves in court or through negotiated resolutions, all as appropriate.

Financial Information

As noted above, 3M will exit all PFAS manufacturing by the end of 2025. The current annual net sales of manufactured PFAS are approximately $1.3 billion with estimated EBITDA margins of approximately 16%. In addition, as also noted above, 3M will work to discontinue the use of PFAS across our product portfolio by the end of 2025, which represents a small portion of 3M’s overall revenue. Over the course of the exit from PFAS manufacturing, 3M expects to incur related total pre-tax charges of approximately $1.3 billion to $2.3 billion, including the fourth quarter 2022 amount below. Approximately 70-80% of the total is expected to be non-cash.

The company expects to take an estimated fourth quarter 2022 pre-tax charge in a range of $0.7 billion to $1.0 billion, primarily non-cash and related to asset impairments.

3M intends to reflect the fourth quarter 2022 costs as an adjustment in arriving at results, adjusted for special items. Beginning in 2023, 3M also expects to adjust for the results of manufactured PFAS in arriving at results, adjusted for special items.

About PFAS

PFAS are critical in the manufacture of many products that are important for modern life, including medical technologies, semiconductors, batteries, phones, automobiles, and airplanes. 3M’s products are safe and effective for their intended uses. Additional details are available on 3M’s website, www.3M.com/PFAS.

About 3M

3M (NYSE: MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news or on Twitter at @3M or @3MNews.

Please note that the company announces material financial, business, and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M news center and social media to communicate with our customers and the public about the company, products and services, and other matters. It is possible that the information 3M posts on the news center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M’s news center and the social media channels, such as Twitter at @3M or @3MNews.

Forward-Looking Statements

This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance, future costs to be incurred or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2021, as updated by the Company's Current Report on Form 8-K dated April 26, 2022, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company's Health Care business, including whether the transaction will be completed, or if completed, will be on the expected terms; the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; the ability to satisfy the various closing conditions; potential business disruption; the diversion of management time; the impact of the transaction (or its pendency) on the Company's ability to retain talent; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment (including whether an Internal Revenue Service private letter ruling will be sought or obtained); the risk that any consents or approvals required will not be obtained; risks associated with financings that may be undertaken and indebtedness that may be incurred in connection with the transaction; (16) matters relating to the voluntary chapter 11 proceedings of the Company's subsidiary Aearo Technologies and certain of its affiliates (the "Aearo Entities"), including legal risks related to the chapter 11 proceedings; potential impacts to the Company's reputation and its relationships with customers, suppliers, employees, regulators and other counterparties and community members; potential impacts to the Company's liquidity or results of operations, including risks related to the amount that will be necessary to fully and finally resolve all of the Company's obligations to make payments to resolve such claims under the terms of its funding and indemnification agreement with the Aearo Entities; and the Aearo Entities' ability to navigate the chapter 11 proceedings to obtain approval and consummation of a plan of reorganization; (17) matters relating to the Company’s plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio (the “exit”), including the actual timing, costs and financial impact of such exit; the Company’s ability to complete such exit, on the anticipated timing or at all; potential governmental or regulatory actions relating to PFAS manufacturing and production, or the Company’s exit plans; the Company’s ability to identify and manufacture acceptable substitutes for the discontinued products, and the possibility that such substitutes will not achieve the anticipated or desired commercial or operational results; potential litigation relating to the Company’s exit plans; and the possibility that the planned exit will involve greater costs than anticipated, or otherwise have negative impacts on the Company’s relationships with its customers and other counterparties. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no

obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

Investor Contacts:

Bruce Jermeland, 651-733-1807

Diane Farrow, 612-202-2449

EX-101.SCH 3 mmm-20221216.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 mmm-20221216_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 mmm-20221216_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Chicago Stock Exchange, Inc. CHICAGO STOCK EXCHANGE, INC [Member] Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Document Information [Line Items] Document Information [Line Items] Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Document Information [Table] Document Information [Table] 1.750% Notes due 2030 Notes 1.750 Percent Due 2030 [Member] Notes bearing 1.750% due 2030. Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Entity Address, Address Line One Entity Address, Address Line One Local Phone Number Local Phone Number Cover [Abstract] 1.500% Notes due 2031 Notes1.500 Percent Due2031 [Member] Notes bearing 1.500% due 2031. Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Common Stock, Par Value $.01 Per Share Common Stock [Member] 0.950% Notes due 2023 Notes 0.950 Percent Due 2023 [Member] Notes bearing 0.950% due 2023. Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Exchange [Domain] Exchange [Domain] Trading Symbol Trading Symbol Document Period End Date Document Period End Date New York Stock Exchange NEW YORK STOCK EXCHANGE, INC. [Member] Class of Stock [Domain] Class of Stock [Domain] Document Type Document Type 1.500% Notes due 2026 Notes 1.500 Percent Due 2026 [Member] Notes bearing 1.500% due 2026. Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 6 mmm-20221216_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover Page	Dec. 16, 2022
Document Information [Line Items]
Document Type	8-K
Document Period End Date	Dec. 16, 2022
Entity Registrant Name	3M COMPANY
Entity Incorporation, State or Country Code	DE
Entity File Number	1-3285
Entity Tax Identification Number	41-0417775
Entity Address, Address Line One	3M Center
Entity Address, City or Town	St. Paul
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55144-1000
City Area Code	651
Local Phone Number	733-1110
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Amendment Flag	false
Entity Central Index Key	0000066740
Common Stock, Par Value $.01 Per Share \| New York Stock Exchange
Document Information [Line Items]
Title of 12(b) Security	Common Stock, Par Value $.01 Per Share
Trading Symbol	MMM
Security Exchange Name	NYSE
Common Stock, Par Value $.01 Per Share \| Chicago Stock Exchange, Inc.
Document Information [Line Items]
Title of 12(b) Security	Common Stock, Par Value $.01 Per Share
Trading Symbol	MMM
Security Exchange Name	CHX
1.500% Notes due 2026 \| New York Stock Exchange
Document Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2026
Trading Symbol	MMM26
Security Exchange Name	NYSE
0.950% Notes due 2023 \| New York Stock Exchange
Document Information [Line Items]
Title of 12(b) Security	0.950% Notes due 2023
Trading Symbol	MMM23
Security Exchange Name	NYSE
1.750% Notes due 2030 \| New York Stock Exchange
Document Information [Line Items]
Title of 12(b) Security	1.750% Notes due 2030
Trading Symbol	MMM30
Security Exchange Name	NYSE
1.500% Notes due 2031 \| New York Stock Exchange
Document Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2031
Trading Symbol	MMM31
Security Exchange Name	NYSE

XML 8 mmm-20221216_htm.xml IDEA: XBRL DOCUMENT 0000066740 2022-12-16 2022-12-16 0000066740 us-gaap:CommonStockMember exch:XNYS 2022-12-16 2022-12-16 0000066740 us-gaap:CommonStockMember exch:XCHI 2022-12-16 2022-12-16 0000066740 mmm:Notes0950PercentDue2023Member exch:XNYS 2022-12-16 2022-12-16 0000066740 mmm:Notes1500PercentDue2026Member exch:XNYS 2022-12-16 2022-12-16 0000066740 mmm:Notes1750PercentDue2030Member exch:XNYS 2022-12-16 2022-12-16 0000066740 mmm:Notes1.500PercentDue2031Member exch:XNYS 2022-12-16 2022-12-16 false 0000066740 8-K 2022-12-16 3M COMPANY DE 1-3285 41-0417775 3M Center St. Paul MN 55144-1000 651 733-1110 false false false false Common Stock, Par Value $.01 Per Share Common Stock, Par Value $.01 Per Share MMM NYSE MMM CHX 0.950% Notes due 2023 MMM23 NYSE 1.500% Notes due 2026 MMM26 NYSE 1.750% Notes due 2030 MMM30 NYSE 1.500% Notes due 2031 MMM31 NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 7 22 1 false 7 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.mmm.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports mmm-20221216.htm a1220228kex-991.htm mmm-20221216.xsd mmm-20221216_def.xml mmm-20221216_lab.xml mmm-20221216_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mmm-20221216.htm": { "axisCustom": 0, "axisStandard": 2, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 37 }, "contextCount": 7, "dts": { "definitionLink": { "local": [ "mmm-20221216_def.xml" ] }, "inline": { "local": [ "mmm-20221216.htm" ] }, "labelLink": { "local": [ "mmm-20221216_lab.xml" ] }, "presentationLink": { "local": [ "mmm-20221216_pre.xml" ] }, "schema": { "local": [ "mmm-20221216.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd" ] } }, "elementCount": 36, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 4, "memberStandard": 3, "nsprefix": "mmm", "nsuri": "http://www.mmm.com/20221216", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mmm-20221216.htm", "contextRef": "ic101f56f823040549f23b4ee41160ca9_D20221216-20221216", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.mmm.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mmm-20221216.htm", "contextRef": "ic101f56f823040549f23b4ee41160ca9_D20221216-20221216", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 7, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsExchangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Listings, Exchange [Axis]", "terseLabel": "Entity Listings, Exchange [Axis]" } } }, "localname": "EntityListingsExchangeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_ExchangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.", "label": "Exchange [Domain]", "terseLabel": "Exchange [Domain]" } } }, "localname": "ExchangeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "exch_XCHI": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHICAGO STOCK EXCHANGE, INC [Member]", "terseLabel": "Chicago Stock Exchange, Inc." } } }, "localname": "XCHI", "nsuri": "http://xbrl.sec.gov/exch/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "exch_XNYS": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK STOCK EXCHANGE, INC. [Member]", "terseLabel": "New York Stock Exchange" } } }, "localname": "XNYS", "nsuri": "http://xbrl.sec.gov/exch/2021", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mmm_Notes0950PercentDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes bearing 0.950% due 2023.", "label": "Notes 0.950 Percent Due 2023 [Member]", "terseLabel": "0.950% Notes due 2023" } } }, "localname": "Notes0950PercentDue2023Member", "nsuri": "http://www.mmm.com/20221216", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mmm_Notes1.500PercentDue2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes bearing 1.500% due 2031.", "label": "Notes1.500 Percent Due2031 [Member]", "terseLabel": "1.500% Notes due 2031" } } }, "localname": "Notes1.500PercentDue2031Member", "nsuri": "http://www.mmm.com/20221216", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mmm_Notes1500PercentDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes bearing 1.500% due 2026.", "label": "Notes 1.500 Percent Due 2026 [Member]", "terseLabel": "1.500% Notes due 2026" } } }, "localname": "Notes1500PercentDue2026Member", "nsuri": "http://www.mmm.com/20221216", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mmm_Notes1750PercentDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes bearing 1.750% due 2030.", "label": "Notes 1.750 Percent Due 2030 [Member]", "terseLabel": "1.750% Notes due 2030" } } }, "localname": "Notes1750PercentDue2030Member", "nsuri": "http://www.mmm.com/20221216", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock, Par Value $.01 Per Share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.mmm.com/role/CoverPage" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0000066740-22-000085-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000066740-22-000085-xbrl.zip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end